{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03158090","recordId":"NCT03158090","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03158090-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03158090.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03158090.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-05-16","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"756aacdb058f3b32594d02c26606d376ba406353278ea81a592002eb5e12852f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-05-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-05-22","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"fa3127d1fb99b72f548da6f71b20c7a5b510a192b5f5d5f68442bbca6016980d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-05-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2018-05-31","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"be4a5919b993596b370977f74c8286d2de9499431643edf6e6e68dbce6c2d50c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-05-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-05-28","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"f742cfd66af1d7e75a8fc1609208d91af163f261fc0f0b28a0b5fcb4334e9904","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2022-03-14","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"e8e8afa816917001a8645372863a2d035c18b626c57990fd79e2fef89bd2ee98","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=5&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"06a2754c03751a0072a1599568419b94b49990734729864f3c7a9caf89a7cfb8"}}
